Sökning: WFRF:(Kadowaki Takashi) >
Heart failure and c...
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes : A large multinational cohort study
-
- Birkeland, Kåre I. (författare)
- Oslo Univ Hosp, Oslo, Norway.;Univ Oslo, Oslo, Norway
-
- Bodegard, Johan (författare)
- AstraZeneca, Oslo, Norway
-
- Eriksson, Jan W. (författare)
- Uppsala universitet,Klinisk diabetologi och metabolism
-
visa fler...
-
- Norhammar, Anna (författare)
- Karolinska Institutet
-
- Haller, Hermann (författare)
- Hannover Med Sch, Div Nephrol, Hannover, Germany
-
- Linssen, Gerard C. M. (författare)
- Hosp Grp Twente, Dept Cardiol, Hengelo, Netherlands
-
- Banerjee, Amitava (författare)
- UCL, Inst Hlth Informat, London, England.;Univ Coll London Hosp, Dept Cardiol, London, England
-
- Thuresson, Marcus (författare)
- Statisticon AB, Uppsala, Sweden
-
- Okami, Suguru (författare)
- AstraZeneca, Osaka, Japan
-
- Garal-Pantaler, Elena (författare)
- Team Gesundheit GmbH, Essen, Germany
-
- Overbeek, Jetty (författare)
- PHARMO Inst Drug Outcomes Res CRS, Utrecht, Netherlands
-
- Mamza, Jil Billy (författare)
- AstraZeneca, Luton, Beds, England
-
- Zhang, Ruiqi (författare)
- AstraZeneca, Luton, Beds, England
-
- Yajima, Toshitaka (författare)
- AstraZeneca, Osaka, Japan
-
- Komuro, Issei (författare)
- Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan
-
- Kadowaki, Takashi (författare)
- Univ Tokyo, Grad Sch Med, Dept Prevent Diabet & Lifestyle Related Dis, Tokyo, Japan.;Teikyo Univ, Mizonokuchi Hosp, Dept Metab & Nutr, Kawasaki, Kanagawa, Japan
-
visa färre...
-
Oslo Univ Hosp, Oslo, Norway;Univ Oslo, Oslo, Norway AstraZeneca, Oslo, Norway (creator_code:org_t)
- 2020-06-03
- 2020
- Engelska.
-
Ingår i: Diabetes, obesity and metabolism. - : John Wiley & Sons. - 1462-8902 .- 1463-1326. ; 22:9, s. 1607-1618
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Aims To examine the manifestation of cardiovascular or renal disease (CVRD) in patients with type 2 diabetes (T2D) initially free from CVRD as well as the mortality risks associated with these diseases.Methods Patients free from CVRD were identified from healthcare records in England, Germany, Japan, the Netherlands, Norway and Sweden at a fixed date. CVRD manifestation was defined by first diagnosis of cardiorenal disease, or a stroke, myocardial infarction (MI) or peripheral artery disease (PAD) event. The mortality risk associated with single CVRD history of heart failure (HF), chronic kidney disease (CKD), MI, stroke or PAD was compared with that associated with CVRD-free status.Results Of 1 177 896 patients with T2D, 772 336 (66%) were CVRD-free and followed for a mean of 4.5 years. A total of 137 081 patients (18%) developed a first CVRD manifestation, represented by CKD (36%), HF (24%), stroke (16%), MI (14%) and PAD (10%). HF or CKD was associated with increased cardiovascular and all-cause mortality risk: hazard ratio (HR) 2.02 (95% confidence interval [CI] 1.75-2.33) and HR 2.05 (95% CI 1.82-2.32), respectively. HF and CKD were separately associated with significantly increased mortality risks, and the combination was associated with the highest cardiovascular and all-cause mortality risk: HRs 3.91 (95% CI 3.02-5.07) and 3.14 (95% CI 2.90-3.40), respectively.Conclusion In a large multinational study of >750 000 CVRD-free patients with T2D, HF and CKD were consistently the most frequent first cardiovascular disease manifestations and were also associated with increased mortality risks. These novel findings show these cardiorenal diseases to be important and serious complications requiring improved preventive strategies.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Nyckelord
- diabetic nephropathy
- heart failure
- macrovascular disease
- observational study
- type 2 diabetes
- SGLT2 inhibitor
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Birkeland, Kåre ...
-
Bodegard, Johan
-
Eriksson, Jan W.
-
Norhammar, Anna
-
Haller, Hermann
-
Linssen, Gerard ...
-
visa fler...
-
Banerjee, Amitav ...
-
Thuresson, Marcu ...
-
Okami, Suguru
-
Garal-Pantaler, ...
-
Overbeek, Jetty
-
Mamza, Jil Billy
-
Zhang, Ruiqi
-
Yajima, Toshitak ...
-
Komuro, Issei
-
Kadowaki, Takash ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
- Artiklar i publikationen
-
Diabetes, obesit ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet